Radiology Associates announced the hiring of John Michael Barraza, Jr., MD. He is a fellowship-trained radiologist, who completed an interventional radiology fellowship at The University of Pennsylvania in Philadelphia, Pa.
“We at Radiology Associates are proud to announce that Dr. Michael Barraza has joined our talented team of subspecialty radiologists,” says Scott B. Schuber, MD, Radiology Associates’ managing partner. “Dr. Barraza is a highly trained and experienced interventional radiologist who will further optimize this growing segment of our practice.”
Barraza graduated with a Bachelor of Arts from Vanderbilt University in Nashville, Tenn. He earned a Doctor of Medicine at The Medical University of South Carolina in Charleston, S.C. He completed a general surgery internship at Ochsner Clinic Foundation in New Orleans, La. and a diagnostic radiology residency at Vanderbilt University.
Barraza is a member of American College of Radiology, Radiological Society of North America, and Society of Interventional Radiology.
“Interventional radiology as a specialty remains inextricably anchored to the forefront of modern medicine, with an established track record of delivering innovative solutions to complex medical issues across virtually all organ systems,” said Barraza. “In caring for patients, we offer a glimpse at the future of medicine, with minimally invasive interventions tailored to individual patients, utilizing cutting edge technology, and state-of-the-art image guidance. I value working alongside physicians of all specialties to identify solutions for each unique patient, and am grateful for the opportunity to apply my expertise to the care of patients in the Baton Rouge community.”
Barraza specializes in minimally invasive therapies for various arterial and venous conditions, degenerative and oncologic pain management, vertebral compression fractures, indwelling IVC filters, and diverse cancer-related issues. He also offers uterine artery and prostatic artery embolization as nonsurgical treatment options for symptomatic uterine fibroids and benign prostatic hypertrophy (BPH), respectively.